Kits Eyecare Ltd.
TSX:KITS.TOSpecialty Retail
-$0.18 today
- Market cap
- $650.54M
- Beta
- 0.20
- P/E (TTM)
- 126.0
- EPS (TTM)
- $0.10
Volume 0.08M
Average 0.14M
KITS.TO Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Kits Eyecare Ltd.TSX: KITS.TO
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns negative
Q1 FY2026 accounts receivables was -CA$813K, compared with CA$610K a year earlier. Trailing-twelve-month accounts receivables was -CA$1.28M.
Context
- Accounts receivables amounted to 0.1% of revenue in FY2025, down 0.4 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near -CA$813K or moves back toward the trailing-twelve-month quarterly average of -CA$320.5K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
CAD · from the cash flow
- Latest · FY2025
- 142K CAD
- Year-over-year change
- +120.2%
- 4-year CAGR
- -32.1%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 142K | +120.2% |
| FY2024 | 2024-12-31 | (703K) | +21.6% |
| FY2023 | 2023-12-31 | (897K) | -96.3% |
| FY2022 | 2022-12-31 | (457K) | -168.3% |
| FY2021 | 2021-12-31 | 669K | — |
Accounts Receivables vs competitors
How KITS.TO compares with its peers on the latest reported figures
- KITS.TO's LTM Mar 2026 accounts receivables of CA$1.28M is the 6th largest of the 10 companies compared; the peer median is CA$974K.
- Its year-over-year change of +255.1% is the 3rd highest of 10, against a peer median of +162.1%.
- Accounts receivables amounts to 0.6% of revenue for KITS.TO, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$33.61M | +175.8% | -42.9% | 5.7% | |
| LTM Mar 2026 | CA$22.2M | +230.1% | — | 0.5% | |
| LTM Mar 2026 | CA$5.67M | +2640.6% | -32.4% | 0.9% | |
| LTM Mar 2026 | CA$2.45M | +162.1% | — | 3.1% | |
| LTM Mar 2026 | CA$1.59M | -224.2% | -42.5% | 0.7% | |
| LTM Mar 2026 | CA$1.28M | +255.1% | — | 0.6% | |
| LTM Apr 2026 | CA$974K | +119.7% | +24.0% | 0.3% | |
| LTM Mar 2026 | CA$276.1K | +6834.1% | -52.7% | 0.3% | |
| LTM Apr 2026 | CA$260K | -103.5% | — | 0.0% | |
| LTM Mar 2026 | CA$123K | -137.8% | -79.2% | 0.3% | |
| Peer median (excluding KITS.TO) | CA$974K | +162.1% | -42.7% | 0.5% | |
Competitors are the stored peer set for KITS.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (14.62M) | (4.55M) | (2.22M) | 3.12M | 3.11M |
| Depreciation & Amortization | 2.67M | 3.52M | 3.19M | 2.66M | 2.38M |
| Deferred Income Tax | (4.23M) | (1.32M) | (676K) | 1.33M | 1.94M |
| Stock-Based Compensation | 1.52M | 1.32M | 513K | 1.01M | 1.09M |
| Change in Working Capital | (6.77M) | 4.07M | 343K | 3.84M | 517K |
| Accounts Receivables | 669K | (457K) | (897K) | (703K) | 142K |
| Inventory | (7.68M) | (2.93M) | 1.01M | (7.08M) | (1.18M) |
| Accounts Payables | (41K) | 6.49M | (703K) | 9.28M | 1.24M |
| Other Working Capital | 278K | 961K | 938K | 2.35M | 313K |
| Other Non-Cash Items | 1.97M | 1.64M | 1.25M | 1.08M | 2.43M |
| Operating Cash Flow | (19.46M) | 4.68M | 2.41M | 13.04M | 11.46M |
| Capital Expenditures | (3.63M) | (258K) | (563K) | (3.15M) | (136K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | (4.99M) |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (3.63M) | (258K) | (563K) | (3.15M) | (5.13M) |
| Debt Repayment | (9.88M) | (5.13M) | (5.14M) | (4.88M) | 3.02M |
| Common Stock Issued | 55M | 0 | 65K | 0 | 1.84M |
| Common Stock Repurchased | 0 | 0 | 0 | (213K) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.64M) | 0 | 65K | 71K | (1.39M) |
| Financing Cash Flow | 41.48M | (5.13M) | (5.07M) | (5.02M) | 3.47M |
| Effect of Forex Changes | (187K) | (1.01M) | 480K | (1.63M) | 736K |
| Net Change in Cash | 18.2M | (1.72M) | (2.75M) | 3.23M | 10.54M |
| Free Cash Flow | (23.09M) | 4.42M | 1.84M | 9.88M | 11.33M |
Kits Eyecare Ltd.
TSX:KITS.TO
Intrinsic Alpha fair value
Locked
Current Price
$19.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.